234 related articles for article (PubMed ID: 22529697)
1. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
[TBL] [Abstract][Full Text] [Related]
3. CD44 loss in gastric stromal tumors as a prognostic marker.
Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
[TBL] [Abstract][Full Text] [Related]
4. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of
Yuan J; Kihara T; Kimura N; Hashikura Y; Ohkouchi M; Isozaki K; Takahashi T; Nishida T; Ito A; Hirota S
Pathol Oncol Res; 2021; 27():602008. PubMed ID: 34257559
[TBL] [Abstract][Full Text] [Related]
9. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
10. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
[TBL] [Abstract][Full Text] [Related]
11. The clinical correlation of phosphatase and tensin homolog on chromosome 10, phosphorylation of AKT to an activated state, and odontogenic ameloblast-associated protein in gastrointestinal stromal tumors.
McLoughlin J; Nodit L; Heidel RE; Van Meter S; Macy S; Kestler D
J Surg Res; 2016 May; 202(2):403-12. PubMed ID: 27229116
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and Prognostic Significance of Expression of B-Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (BMI-1) Gene and Protein in Gastrointestinal Stromal Tumors.
Zhu K; Li K; Yuan DW; Xu G; Kang L; Dang CX; Zhang Y
Med Sci Monit; 2018 Sep; 24():6414-6421. PubMed ID: 30209248
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 expression score correlates to survival rate in gastrointestinal stromal tumors (GIST).
Artigiani Neto R; Logullo AF; Stávale JN; Lourenço LG
Acta Cir Bras; 2012 May; 27(5):315-21. PubMed ID: 22666745
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological feature and prognosis of primary hepatic gastrointestinal stromal tumor.
Liu Z; Tian Y; Liu S; Xu G; Guo M; Lian X; Fan D; Zhang H; Feng F
Cancer Med; 2016 Sep; 5(9):2268-75. PubMed ID: 27484851
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
Lasota J; Wang Z; Kim SY; Helman L; Miettinen M
Am J Surg Pathol; 2013 Jan; 37(1):114-9. PubMed ID: 22892600
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis.
Pyo JS; Kang G; Sohn JH
Int J Biol Markers; 2016 May; 31(2):e204-10. PubMed ID: 26616229
[TBL] [Abstract][Full Text] [Related]
19. Gastric and Small Intestine Gist: Results of 156 Cases in 20 Years.
Lopez Gordo S; Bettonica C; Miró M; Estremiana F; Aranda H; Farran L
J Gastrointest Cancer; 2022 Jun; 53(2):451-459. PubMed ID: 33871798
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
